Key result
Class I antiarrhythmics blocking diastolic sodium current inhibit guinea pig pulmonary vein automaticity.
Why the study?
The effects of class I antiarrhythmic drugs on the automaticity of pulmonary vein myocardium and their relation to diastolic sodium current blockade were unclear.
Class I antiarrhythmic drugs that block the diastolic sodium current component inhibit the automaticity of the pulmonary vein myocardium in a preclinical model.
Answers are grounded in this paper and cite their sources.
May indicate variable PV automaticity suppression among class I agents; leaves open clinical translation for AF.
The effects of class I antiarrhythmic drugs on the automaticity of isolated guinea pig pulmonary vein myocardia were investigated using microelectrode and voltage clamp methods. All of the drugs examined reduced the maximum rate of rise of automatic action potentials. The firing frequency and rate of diastolic depolarization were decreased by aprindine, flecainide and propafenone, but not by cibenzoline, disopyramide and pilsicainide, which correlated with blockade of the sodium current component induced by ramp depolarization mimicking the diastolic depolarization. In conclusion, class I antiarrhythmic drugs which block the diastolic sodium current component inhibit the automaticity of the pulmonary vein myocardium.
No takes yet. Share an insight, caveat, or question.
Irie et al. (2020) studied this question. Class I antiarrhythmic drugs was evaluated on Automaticity (firing frequency and rate of diastolic depolarization). Class I antiarrhythmic drugs that block the diastolic sodium current component (aprindine, flecainide, propafenone) inhibit the automaticity of the guinea pig pulmonary vein myocardium.
Synapse has enriched 10 related papers. Consider them for comparative context: